Managing Risks with Newer Oral Small Molecules in Patients with Inflammatory Bowel Diseases.

Curr Gastroenterol Rep

Division of Gastroenterology, John T. Milliken Department of Medicine, Washington University School of Medicine, 660 S. Euclid Avenue, Campus, Box 8124, St. Louis, MO, 63110, USA.

Published: May 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Purpose Of Review: Treatment of Inflammatory Bowel Diseases (IBD) is challenging; thus, the need for newer therapeutic options with an oral route of administration has led to the development of novel small molecules drugs (SMDs). We aim to highlight the most common Adverse events (AEs) associated with SMDs and recommendations on monitoring for AEs before and during treatment.

Recent Findings: SMDs, such as Tofacitinib, a JAK inhibitor, have been associated with laboratory abnormalities, infections, and risk of thromboembolic events. Therefore, oral agents with greater selectivity in JAK inhibition, such as tofacitinib and upadacitinib, were later developed. Ozanimod and etrasimod, S1PR agonists, require closer safety profile monitoring by clinicians. Multiple therapies have been recently developed with variable efficacy. However, they have been associated with AEs, and some require close monitoring prior to and during therapy. Clinicians should highlight these adverse events to patients while reassuring the safety profile of these novel SMDs for IBD is favorable.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11894-024-00923-xDOI Listing

Publication Analysis

Top Keywords

small molecules
8
inflammatory bowel
8
bowel diseases
8
adverse events
8
safety profile
8
managing risks
4
risks newer
4
newer oral
4
oral small
4
molecules patients
4

Similar Publications

Solvent-Directed Self-Assembly of Sorafenib into Spherical Particles for Enhanced Anticancer Efficacy.

Nano Lett

September 2025

KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul 02841, Republic of Korea.

Sorafenib, a clinically approved multityrosine kinase inhibitor, exhibits poor aqueous solubility, which limits its bioavailability and therapeutic efficacy. In this study, we introduce a solvent-directed self-assembly strategy to modulate the nanostructure of sorafenib without the use of external carriers or complex formulation techniques. In pure water, sorafenib forms large lamellar aggregates, whereas in 30% methanol-water mixtures, it self-assembles into uniform spherical particles approximately 450 nm in diameter.

View Article and Find Full Text PDF

Secreted frizzled-related protein 4 (sFRP4) plays a fundamental role in the regulation of Wnt signalling, which is crucial for cellular proliferation and differentiation. The sFRP4 has garnered significant interest as a therapeutic target for metabolic diseases and cancer due to its mechanism of action. Although existing sFRP4 modulators show limited specificity and notable off-target effects, our study explores the potential of known bioactive compounds as more selective and less toxic alternatives.

View Article and Find Full Text PDF

Electrolytes are important components in lithium-ion batteries. However, battery degradation due to irreversible electrochemical reactions in the electrolyte can consume electrolyte molecules and severely reduce its effective operation lifetime. It is hence important to study the electrochemical reaction pathways in the battery electrolyte to further improve lithium-ion battery reliability.

View Article and Find Full Text PDF

Investigation of the small molecule-aptamer interaction is difficult, and it usually lacks information about the conformational change of aptamers that is important for their application. Here, we present the label-free investigation of small molecule-aptamer interactions using a modularized organic electrochemical transistor (OECT) platform. Leveraging the high sensitivity of the OECT, we measured the conformational change of the aptamer encountering its ligand.

View Article and Find Full Text PDF

Real-Space Quantitative Molecular Analysis at Single-Molecule Resolution.

J Am Chem Soc

September 2025

Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, Suzhou 215123, Jiangsu P. R. China.

Advances in molecular analysis and characterization techniques should revolutionize the methods for scientific exploration across physics, chemistry, and biology, fundamentally overturning our understanding of interactions and processes that govern molecular behavior at the microscopic level. Currently, the absence of a molecular analysis method that can both quantify molecules and achieve single-molecule spatial resolution hinders our study of complex molecular systems in sorption and catalysis. Here, we propose a quantitative analysis strategy for small molecules confined in ZSM-5, a zeolite material extensively used in catalysis and gas separation, based on low-dose transmission electron microscopy.

View Article and Find Full Text PDF